Breakthrough cryptococcosis in a patient with systemic lupus erythematosus (SLE) receiving micafungin

Journal of Infection and Chemotherapy

Volumn 14, Issue 4, 2008, Pages 311-314

  Suzuki, Kei ^a,b   Nakase, Kazunori ^b   Ino, Kazuko ^a,b   Sugawara, Yumiko ^a,b   Sekine, Takao ^a   Katayama, Naoyuki ^b  

^a Matsusaka Chuo General Hospital   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cryptococcus neoformans; Micafungin

Indexed keywords

ANTIFUNGAL AGENT; DIURETIC AGENT; ECHINOCANDIN; FLUCONAZOLE; GANCICLOVIR; MEROPENEM; METHYLPREDNISOLONE; MICAFUNGIN; MIZORIBINE; PREDNISOLONE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; HUMAN; INFECTION; KIDNEY BIOPSY; LUMBAR PUNCTURE; LUNG ASPERGILLOSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 50049085642     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0616-1     Document Type: Article

References (14)

1. C. Rieger S. Geiger T. Herold C. Nickenig H. Ostermann 2007 Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukemia Eur J Clin Microbiol Infect Dis 26 843 845
2. V. Krcmery Jr E. Oravcova S. Spanik M. Mrazova-Studena J. Trupl A. Kunova 1998 Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome J Antimicrob Chemother 41 373 380
3. K. Matsue H. Uryu M. Koseki N. Asada M. Takeuchi 2006 Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin Clin Infect Dis 42 753 757
4. T. Akagi K. Yamaguti T. Kawamura T. Nakamura K. Kubo H. Takemori 2006 Breakthrough trichosporonosis in patients with acute myeloid leukemia receiving micafungin Leuk Lymphoma 47 1182 1183
5. P.H. Chandrasekar J.D. Sobel 2006 Micafungin: a new echinocandin Clin Infect Dis 42 1171 1178
6. J.M. Joseph R. Jain L.H. Danziger 2007 Micafungin: a new echinocandin antifungal Pharmacotherapy 27 53 67
7. S. Tawara F. Ikeda K. Maki Y. Morishita K. Otomo N. Teratani 2000 In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi Antimicrob Agents Chemother 44 57 62
8. A. Espinel-Ingroff 1998 Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743, 872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts J Clin Microbiol 36 2950 2956
9. O. Uzun S. Kocagos Y. Cetinkaya S. Arikan S. Unal 1997 In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates Antimicrob Agents Chemother 41 1156 1157
10. J.A. van Burik V. Ratanatharathorn D.E. Stepan C.B. Miller J.H. Lipton D.H. Vesole 2004 Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation Clin Infect Dis 39 1407 1416
11. C.C. MoK C.S. Lau K.Y. Yuen 1998 Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus Clin Exp Rheumatol 16 169 171
12. B. Zimmermann 3rd M. Spiegel E.V. Lally 1992 Cryptococcal meningitis in systemic lupus erythematosus Semin Arthritis Rheum 22 18 24
13. D.P. Kontoyiannis W.K. Peitsch B.T. Reddy E.E. Whimbey X.Y. Han G.P. Bodey 2001 Cryptococcosis in patients with cancer Clin Infect Dis 32 E145 E150
14. D.L. Kiska D.R. Orkiszewski D. Howell P.H. Gilligan 1994 Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid J Clin Microbiol 32 2309 2311